Revefenacin
Revefenacin (TD-4208) is a potent and selective long-acting muscarinic M3 receptor antagonist (Ki = 0.18 nM) . It is a research compound investigated for chronic obstructive pulmonary disease (COPD), with studies demonstrating its bronchodilatory effects in both in vitro assays and in vivo models.
Product Specifications
CAS Number
864750-70-9
Product Name Alternative
Inhibitor, GSK 1160724, GSK1160724, GSK-1160724, inhibit, Muscarinic acetylcholine receptor, mAChR, Revefenacin, TD 4208, TD4208, TD-4208
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
96.66% (May vary between batches)
Solubility
DMSO:49 mg/mL (81.97 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.69 mM)
Smiles
CN (CCN1CCC (CC1) OC (=O) Nc1ccccc1-c1ccccc1) C (=O) c1ccc (CN2CCC (CC2) C (N) =O) cc1
Molecular Formula
C35H43N5O4
Molecular Weight
597.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ROR2 (Receptor Tyrosine Kinase-like orphan Receptor 2, BDB, BDB1, MGC163394, NTRKR2) (FITC)
PGAP1 (GPI Inositol-deacylase, Post-GPI Attachment to Proteins Factor 1, hPGAP1, UNQ3024/PRO9822) (APC)